MAPK3 and lung carcinoma: Regarding the lung cancer model, increased expression of markers of cell proliferation like proliferating cell nuclear antigen (PCNA) and ERK1/2 activation which play an important role in the pathogenesis of lung cancer is associated with increased expression of T3 and/or T4.